Session 2: Histamine Receptors: An Overview

References

• Dale H H, Laidlaw P P. The physiological action of iminazolylethylamine. J Physiol 1910; 41(B)318–344
   PubMedGoogle Scholar
• Dale H H, Laidlaw P P. Further observations on the action of beta-imidazolyl-ethylamine. J Physiol 1911; 43: 182–195
   PubMedGoogle Scholar
• Dale H H, Laidlaw P P. Histamine shock. J Physiol 1919; 52: 355–390
   PubMedGoogle Scholar
• Popielski L. β-Imidazolylathylamine und de organextrakte: β-Imidazolylathylamine als mach-tiger erreger der magendruson. Pfluegers Arch 1920; 178: 214–226
   Google Scholar
• Bovet D, Staub A-M. Action protectrice des ethers phenoliques au cows de I'intoxication histaminique. C R Soc Biol (Pans) 1937; 125: 547–549
   Google Scholar
• Bovet D, Horclois R, Walthert F. Propriétés anti-histaminique de la N-p-methoxybenzyl N-di-methylaminoethyl-α-amino-pyridine. CR Soc Biol (Paris) 1944; 138: 99–100
   Google Scholar
• Loew E R, MacMillan R, Kaiser M E. Antihistamine properties of benadryl, β-dimethylaminoethyl benzhydryl ether hydrochloride. J Pharmacol Exp Ther 1946; 86: 229–238
   PubMedGoogle Scholar
• Halpern B N, Mauric G. Étude quantitative de I'antagonisme de l'histamine et d'un antihista-minique de synthèse (Antergan) sur I'intestin isolé de cobaye. CR Soc Biol (Paris) 1946; 140: 440–443
   Google Scholar
• Schild H O. pA, A new role for the measurement of drug antagonism. Br J Pharmacol Chemother 1947; 2: 189–206
   PubMed Web of Science ®Google Scholar
• Trendelenburg U. The action of histamine and 5–hydroxytryptamine on isolated mammalian atria. J Pharmacol Exp Ther 1960; 130: 450–460
   PubMed Web of Science ®Google Scholar
• Dews P B, Graham J DP. The antihistamine substance 2786 RP. Br J Pharmacol Chemother 1946; 1: 278–286
   PubMed Web of Science ®Google Scholar
• Loew E R. Pharmacology of antihistamine compounds. Physiol Rev 1947; 27: 542–573
   PubMed Web of Science ®Google Scholar
• Folkow B, Haeger K, Kahlson G. Observations on reactive hyperaemia as related to histamine, on drugs antagonising vasodilatation induced by histamine and on vasodilator properties of adenosine triphosphate. Acta Physiol Scand 1948; 15: 264–278
   Google Scholar
• Ganellin C R. Chemistry and structure-activity relationships of drugs acting at histamine receptors. Pharmacology of histamine receptors, C R Ganellin, M E Parsons. Wright PSG, Bistol 1982; 10–102
   Google Scholar
• Parsons M E. Quantitative studies of drug-induced acid gastric secretion. Ph.D. Thesis, University of London, London 1969
   Google Scholar
• Ash A SF, Schild H O. Receptors mediating some actions of histamine. Br J Pharmacol Chemother 1966; 27: 427–439
   PubMed Web of Science ®Google Scholar
• Durant G J, Parsons M E, Black J W. Potential histamine Hz-receptor antagonists. 2,Nα-guanylhis-tamine. J Med Chem 1975; 18: 830–833
   PubMedGoogle Scholar
• Parsons M E, Blakemore R C, Durant G J, Ganellin C R, Rasmussen A C. 3–[4–(5)-Imidazolyl]-propyl-guanidine (SK&F 91486)—a partial agonist at histamine H2-receptors. Agents Actions 1975; 5: 464
   PubMedGoogle Scholar
• Ganellin C R. Selectivity and design of histamine H2-receptor antagonists. J Appl Chem Biotechnol 1978; 28: 183–200
   Google Scholar
• Black J W, Duncan W AM, Durant G J, Ganellin C R, Parsons M E. Definition and antagonism of histamine H,-receptors. Nature 1972; 236: 385–390
   PubMed Web of Science ®Google Scholar
• Parsons M E. Mechanism of acid secretion. Topics in gastroenterology, D R Jewell, J R Lowes. Blackwell Scientific Publications, Oxford 1989; Vol. 16: 39–48
   Google Scholar
• Black J W, Duncan W AM, Emmett J C, et al. Meti-amide—an orally active histamine H2-receptor antagonist. Agents Actions 1973; 3: 133–137
   PubMedGoogle Scholar
• Brimblecombe R W. Duncan WAM, Durant GJ, et al. Characterization and development of cimetidine as a histamine H,-receptor antagonist. Gastroenterology 1978; 74: 339–347
   PubMed Web of Science ®Google Scholar
• Bradshaw J, Brittain R T, Clitherow J W, et al. Ran-itidine (AH 19065): a new potent, selective histamine H2-receptor antagonist. Br J Pharmacol 1979; 64: 464P
   Google Scholar
• Blakemore R C, Brown T H, Durant G J, et al. SK&F 93479, a potent and long acting histamine H,-recep-tor antagonist. Br J Pharmacol 1981; 74: 200P
   Google Scholar
• Stables R, Daly M J, Humphray J. Comparison of the antisecretory potency and duration of action of the Hz-receptor antagonist AH 22216, cimetidine. rantidine and SK&F 93479 in the dog. Agents Actions 1983; 13: 166–168
   PubMedGoogle Scholar
• Betton G R, Salmon G K. Neuroendocrine carcinoid tumours of the glandular stomach of the rat following treatment with the H2-receptor antagonist SK&F 93479. 26th Congress of the European Society of Toxicology, Kupio, 1985, Abstract P32
   Google Scholar
• Poynter D, Pick C R, Harcourt R A, et al. Association of long lasting unsurmountablc histamine H1 blockade and gastric carcinoid tumours in the rat. Gut 1985; 26: 1284–1295
   PubMed Web of Science ®Google Scholar
• Parsons M E, Owen D AA, Ganellin C R, Durant G J. Dimaprit-(5–[3–(N,N-dimethylamino)-propyl]-isothiourea)—a highly specific histamine H2-recep-tor agonist. I. Pharmacol Agents Actions 1977; 7: 31–37
   PubMedGoogle Scholar
• Durant G J, Duncan W AM, Ganellin C R, Parsons M E, Blakemore R C, Rasmussen A C. Impromidine (SK&F 92676) is a very potent and selective agonist for histamine H2-receptors. Nature 1978; 276: 403–405
   PubMed Web of Science ®Google Scholar
• Arrang J-M, Garbarg M, Schwartz J-C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 1983; 302: 832–837
   PubMed Web of Science ®Google Scholar
• Chang N, Eyre P. Atypical (relaxant) response to histamine in cat bronchus. Agents Actions 1977; 7: 183–190
   PubMedGoogle Scholar
• Ambache N, Kilick S W, Aboo Zar M. Antagonism by burimamide of inhibition induced by histamine in plexus containing longitudinal muscle preparations from the guinea-pig ileum. Br J Pharmacol 1973; 48: 362P–363P
   Google Scholar
• Arrang J-M, Garbarg M, Lancelot J C, et al. Highly potent and selective ligands for histamine H3-recep-tors. Nature 1987; 327: 117–123
   PubMed Web of Science ®Google Scholar
• Ganellin C R, Parsons M E. Pharmacology of histamine receptors. Wright PSG, Bristol 1982
   Google Scholar
• Paton W DM, Vane J R. An analysis of the response of the isolated stomach to electrical stimulation and drugs. J Physiol 1963; 165: 10–46
   PubMed Web of Science ®Google Scholar
• Ohga A, Taneika T. HI- and H2-receptors in the smooth muscle of the ruminant stomach. Br J Pharmacol 1978; 62: 333–337
   PubMed Web of Science ®Google Scholar
• Hervatin F, Dubrasquet M, Lewin M JM. Histamine H3-receptors in the regulation of gastrin stimulated gastric acid secretion in the conscious cat. Gastroenterology 1989; 96: A207
   Google Scholar
• Flynn S B. Owen DAA. Histamine receptors in peripheral vascular beds in the cat. Br J Pharmacol 1975; 55: 181–188
   PubMed Web of Science ®Google Scholar
• Harvey C A, Owen D AA, Shaw K D. Evidence for both histamine H1- and H2-receptors in cat gastric vasculature. Br J Pharmacol 1980; 69: 21–28
   PubMed Web of Science ®Google Scholar
• Ichinose M, Stretton C D, Schwartz J-C, Barnes P J. Histamine H,-receptors inhibit cholinergic neuro-transmission in guinea-pig airways. Br J Pharmacol 1989; 97: 13–15
   PubMedGoogle Scholar
• Bristow L J, Bennett G W. A role for histamine H3-receptors in histamine induced hypoactivity in the rat. Br J Pharmacol 1988; 94: 319P
   PubMedGoogle Scholar
• Durant G J, Ganellin C R, Griffiths R, Harvey C A, Owen D AA, Sach G S. Some newer HI-receptor histamine antagonists. Advances in the biosciences. Vol. 51. Frontiers in histamine research, C Ganellin, R J-C Schwartz. Pergammon Press, Oxford 1985; 3–11
   Google Scholar
• Lorenz W, Doenicke A, Schoning B, et al. HI and Hz-receptor antagonists for premedication in anaesthesia and surgery: a critical view based on randomized clinical trials with haemaccel and various antiallergic drugs. Agents Actions 1980; 10: 114–124
   PubMedGoogle Scholar